Salim Dhanji
Directeur Général chez ME THERAPEUTICS HOLDINGS INC.
Fortune : 21 M $ au 31/05/2024
Postes actifs de Salim Dhanji
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ME THERAPEUTICS HOLDINGS INC. | Directeur/Membre du Conseil | 09/03/2023 | - |
| Directeur Général | 09/03/2023 | - |
Historique de carrière de Salim Dhanji
Anciens postes connus de Salim Dhanji
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Qu Biologics, Inc.
 Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Corporate Officer/Principal | 01/01/2009 | 01/01/2014 |
Formation de Salim Dhanji
| University of British Columbia | Doctorate Degree |
Statistiques
Internationale
| Canada | 4 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ME THERAPEUTICS HOLDINGS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Health Technology |
- Bourse
- Insiders
- Salim Dhanji
- Expérience
